# Healthcare Decisions Post-Testing, Risk-reducing and Preventative Strategies Using LYNCH Genetic Testing Reducing, and Preventative Strategies Using LYNCH Genetic Testing

> **NCT03322176** · — · UNKNOWN · sponsor: **Data Collection Analysis Business Management** · enrollment: 200 (estimated)

## Conditions studied

- Colon Cancer
- Endometrial Cancer

## Interventions

- **OTHER:** Genetic testing

## Key facts

- **NCT ID:** NCT03322176
- **Lead sponsor:** Data Collection Analysis Business Management
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-10-17
- **Primary completion:** 2020-10-17
- **Final completion:** 2020-11-01
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2019-01-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03322176

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03322176, "Healthcare Decisions Post-Testing, Risk-reducing and Preventative Strategies Using LYNCH Genetic Testing Reducing, and Preventative Strategies Using LYNCH Genetic Testing". Retrieved via MORVS 2026-10-05 from https://api.morvs.ai/clinical/NCT03322176. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*